Bimatoprost Sandoz 0,1 mg/ml eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bimatoprost sandoz 0,1 mg/ml eye drops sol. dropper cont.

sandoz sa-nv - bimatoprost 0,1 mg/ml - eye drops, solution - 0,1 mg/ml - bimatoprost 0.1 mg/ml - bimatoprost

Bimatoprost EG 0.3 mg/ml eye drops sol. single-dose cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bimatoprost eg 0.3 mg/ml eye drops sol. single-dose cont.

eg sa-nv - bimatoprost 0,3 mg/ml - eye drops, solution in single-dose container - 0,3 mg/ml - bimatoprost 0.3 mg/ml - bimatoprost

Apo-Bimatoprost New Zealand - English - Medsafe (Medicines Safety Authority)

apo-bimatoprost

apotex nz ltd - bimatoprost 0.3 mg/ml;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml   excipient: benzalkonium chloride citric acid dibasic sodium phosphate hydrochloric acid sodium chloride sodium hydroxide - apo-bimatoprost is indicated as a monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

BIMTOP bimatoprost 300 microgram/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

bimtop bimatoprost 300 microgram/ml eye drop bottle

viatris pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops - excipient ingredients: sodium hydroxide; hydrochloric acid; dibasic sodium phosphate; benzalkonium chloride; citric acid monohydrate; water for injections; sodium chloride - bimtop is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

Bimatoprost Sandoz New Zealand - English - Medsafe (Medicines Safety Authority)

bimatoprost sandoz

sandoz new zealand limited - bimatoprost 0.3 mg/ml;  ;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml     excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - bimatoprost sandoz is indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

APO-BIMATOPROST SOLUTION Canada - English - Health Canada

apo-bimatoprost solution

apotex inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs

APO-BIMATOPROST SOLUTION Canada - English - Health Canada

apo-bimatoprost solution

apotex inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs

LUMIGAN bimatoprost 300 micrograms/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lumigan bimatoprost 300 micrograms/ml eye drops bottle

abbvie pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; dibasic sodium phosphate heptahydrate; sodium chloride - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.

GANFORT PF 0.3/5 bimatoprost 0.3 mg/mL and timolol (as maleate) 5.0 mg/mL eye drops Australia - English - Department of Health (Therapeutic Goods Administration)

ganfort pf 0.3/5 bimatoprost 0.3 mg/ml and timolol (as maleate) 5.0 mg/ml eye drops

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

GANFORT 0.3/5 bimatoprost 0.3 mg/mL & timolol (as maleate) 5.0 mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ganfort 0.3/5 bimatoprost 0.3 mg/ml & timolol (as maleate) 5.0 mg/ml eye drops bottle

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; hydrochloric acid; sodium chloride - ganfort eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.